newsfilter
← Latest News
GlobeNewswire·

iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, in collaboration with AstralBio Inc., announced today the development of an antibody